Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
32results about How to "Early stage" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Control device, image forming apparatus, method of controlling image forming apparatus, and recording medium
ActiveUS20090148006A1Avoid viewingEarly stageCharacter and pattern recognitionPictoral communicationPattern recognitionComputer printing
A control device of the present invention includes: a face position detecting section for detecting a position of a user's face in an image captured by a capturing device; a face recognition processing section for checking a partial image against reference face images, the partial image being at the position detected in the captured image, and extracting a reference face image that matches the face in the partial image; a user authentication section for specifying a user name that corresponds to the extracted reference face image; and a data checking section for (i) checking whether or not a multifunction printer receives print data added with the specified user name, and (ii) if it is confirmed that the multifunction printer receives the print data, operating an image forming section of the multifunction printer to form an image based on the print data. This realizes a control device which (i) authenticates a user in an easy way in which impersonation can be prevented without inconvenient operation, and (ii) prevents another user from accidentally viewing a printed matter.
Owner:SHARP KK
Compounds and method for the prevention and treatment of diabetic retinopathy
InactiveUS6440933B1Reduce deliveryBlock deliverySenses disorderSomatostatinsDiabetic retinopathyDipeptide
The invention provides peptide derivatives designed to deliver peptides having growth factor inhibitory activity, especially somatostatin analogs, to the retina by sequential metabolism. The peptide derivatives, which comprise a dihydropyridine<CUSTOM-CHARACTER FILE="US06440933-20020827-P00900.TIF" ALT="custom character" HE="20" WI="20" ID="CUSTOM-CHARACTER-00001" / >pyridinium salt-type redox targetor moiety, a bulky lipophilic function and an amino acid / dipeptide / tripeptide spacer, are used in the prevention and treatment of diabetic retinopathy.
Owner:UNIV OF FLORIDA RES FOUNDATION INC
Compositions and methods for prognosis of cancers
InactiveUS7402389B2Early stageLower Level RequirementsMicrobiological testing/measurementProstate cancerOncology
The present invention provides compositions and methods of using the EPHB2 gene or its related signaling pathways to detect, prognosticate, assess the risk of, prevent, or treat cancers. Cancers amenable to the present invention include, but are not limited to, prostate cancer, breast cancer, and neuroblastoma. In one aspect, the present invention provides compositions which comprise an agent capable of eradicating or alleviating an abnormality in the EPHB2 gene or its related signaling pathways. This abnormality may cause or contribute to the development or progression of cancers. In another aspect, the present invention provides methods comprising detecting an abnormality in the EPHB2 gene or its related signaling pathways. The presence or absence of such an abnormality is indicative of the risk or disease status of cancer in a person of interest.
Owner:TRANSLATIONAL GENOMICS RES
Vehicle Controller and Controlling Method
InactiveUS20090192681A1Level of possibilityEarly stageHybrid vehiclesDigital data processing detailsAir cycleEngineering
An ECU executes a program including the steps of: detecting a distance to an object; changing over a changeover damper from an inside air circulation to an outside air circulation when a collision is predicted; controlling a power window device to move down a door glass; turning an SMR off when the collision is detected; and controlling the power window device to fully open the door glass.
Owner:TOYOTA JIDOSHA KK
System, computer-readable medium, method, and use for combined eipthelial early cancer diagnosis and staging
InactiveUS20100056927A1Reduce eliminateEarly stageRadiation pyrometryDiagnostics using spectroscopyPath lengthMedicine
A system (40) for diagnosis and staging of early stages of cancer in the tissue of a patient is provided. The system is configured to combine information from a Polarized Light Scattering Spectroscopy measurement (70) having a first probe depth, and a Differential Path Length Spectroscopy measurement (60) having a second probe depth, wherein the second probe depth is set larger than' the first probe depth. By comparing the results of the Polarized Light Scattering Spectroscopy and Differential Path Length Spectroscopy measurements early stages of cancer, such as dysplasia may be detected. Also hyperplasia, carcinoma in situ, and carcinoma may be detected. A computer-readable medium, method and use are also provided.
Owner:KONINKLIJKE PHILIPS ELECTRONICS NV
Compositions and methods for prognosis, diagnosis, prevention and treatment of cancers
InactiveUS20050196796A1Suppress growthLack of functionMicrobiological testing/measurementNeuroblastomaBreast cancer
The present invention provides compositions and methods of using the EPHB2 gene or its related signaling pathways to detect, prognosticate, assess the risk of, prevent, or treat cancers. Cancers amenable to the present invention include, but are not limited to, prostate cancer, breast cancer, and neuroblastoma. In one aspect, the present invention provides compositions which comprise an agent capable of eradicating or alleviating an abnormality in the EPHB2 gene or its related signaling pathways. This abnormality may cause or contribute to the development or progression of cancers. In another aspect, the present invention provides methods comprising detecting an abnormality in the EPHB2 gene or its related signaling pathways. The presence or absence of such an abnormality is indicative of the risk or disease status of cancer in a person of interest.
Owner:TRANSLATIONAL GENOMICS RES
Control device, image forming apparatus, method of controlling image forming apparatus, and recording medium
ActiveUS8289546B2Avoid viewingEarly stageCharacter and pattern recognitionPictoral communicationImage InspectionLocation detection
A control device of the present invention includes: a face position detecting section for detecting a position of a user's face in an image captured by a capturing device; a face recognition processing section for checking a partial image against reference face images, the partial image being at the position detected in the captured image, and extracting a reference face image that matches the face in the partial image; a user authentication section for specifying a user name that corresponds to the extracted reference face image; and a data checking section for (i) checking whether or not a multifunction printer receives print data added with the specified user name, and (ii) if it is confirmed that the multifunction printer receives the print data, operating an image forming section of the multifunction printer to form an image based on the print data. This realizes a control device which (i) authenticates a user in an easy way in which impersonation can be prevented without inconvenient operation, and (ii) prevents another user from accidentally viewing a printed matter.
Owner:SHARP KK
Device for prevention of shunt stenosis
ActiveUS20140257165A1Easy constructionAvoid problemsBalloon catheterOther blood circulation devicesVeinHaemodialysis machine
A method and a kit for the prevention of venous stenosis associated with the use of hemodialysis AV shunts. The kit may use a bifurcated needle for providing access to the shunt or blood vessel. One of the arms is used for returning the blood to the subject after dialysis treatment, while the other arm is used for inserting a device for cleaning the vein, the device being either an autonomous crawling device, or a passive tethered device moved down the vein by the blood flow. The autonomous crawling device may be a series of sequentially inflatable chambers, the stenosis being cleared by pressure from the outer walls of the chambers when inflated and moved. The passive device may be an element having a flexible disc-like structure, whose flexible peripheral edge slides along the inner walls of the blood vessel, compressing or clearing the material attached thereto.
Owner:MICROBOT MEDICAL LTD
DNA Conformation
ActiveUS20090186352A1Easily detectEasy to detectMicrobiological testing/measurementGene expressionBiology
Method of detection or diagnosis of abnormal gene expression in an individual comprising determining in a sample from the individual the presence or absence of a chromosome structure in which two separate regions of the gene have been brought into close proximity, to thereby detect or diagnose whether the individual has abnormal gene expression.
Owner:OXFORD UNIV INNOVATION LTD
In vivo imaging method
InactiveUS20110236307A1DelayAvoid symptomsGeneral/multifunctional contrast agentsRadioactive preparation carriersDiagnosis earlyNeural cell
The present invention provides an in vivo imaging method that facilitates the diagnosis of Parkinson's disease (PD) at an early stage. Early diagnosis is particularly advantageous as neuroprotective treatment can be applied to healthy neural cells to delay or even prevent the onset of debilitating clinical symptoms.
Owner:GE HEALTHCARE LTD
Tau imaging probe
InactiveUS20160008494A1Improve securitySatisfactory sensitivityNervous disorderIsotope introduction to heterocyclic compoundsConformational isomerismCrystallography
An object of the present invention is to provide a probe for imaging a β-sheet structure protein which can be used for the diagnosis of conformational diseases, particularly disease (tauopathy) having a cardinal symptom such as intracerebral accumulation of tau protein, for example, Alzheimer's disease. Another object of the present invention is to provide a compound which is highly specific to tau and can image tau with satisfactory sensitivity, and also has high brain transition, low or non-recognized bone-seeking properties and low or non-recognized toxicity.According to the present invention, the above problems are solved by providing a compound of a formula I (wherein A, R1, R2, R3, R4, R5, R6, Ra and Rb are as defined in the present description) or a pharmaceutically acceptable salt or solvate thereof.
Owner:GE HEALTHCARE LTD
Method of treatment for early stage cancer
InactiveUS20080269135A1Easy to solveEarly stageBiocidePeptide/protein ingredientsDiseaseAcquired resistance
This patent describes a method and materials to treat cancer diagnosed at an early stage, particularly breast cancer. It considers that metastatic breast cancer growth includes periods of dormancy, that surgery to remove a primary tumor can induce metastatic growth, and that women with Down Syndrome rarely get breast cancer. It elevates the level of an antiangiogenic drug produced by chromosome 21 preferably Endostatin in plasma preferably at least one day prior to surgery and kept at that high level preferably indefinitely. The therapy specifically excludes drugs that significantly inhibit the VEGF pathway since that is important for wound healing. This method will prevent results of surgery from stimulating tumor growth and angiogenesis of micrometastatic disease that is much easier to prevent than control after the fact. This can be done indefinitely since there is no acquired resistance that develops, as happens in most cancer therapies.
Owner:RETSKY MICHAEL W
Vehicle seat with side airbag apparatus
ActiveUS20180093633A1Prevent and suppressReduce distanceBack restsPedestrian/occupant safety arrangementPlan sectionLateral airbag
In a vehicle seat, a gas generating device of a side airbag apparatus is attached to the inside of an outer side frame in a seat-width direction. When a seated occupant is a three-dimensional mannequin of AM50, a portion of the gas generating device overlaps a back pan of the three-dimensional mannequin as viewed in a seat front-rear direction. Here, in a plan section of a seat back in a range in which the gas generating device is positioned in a seat up-down direction, when an imaginary line overlapping a section of the back pan is moved back toward a seat rear side until the imaginary line comes into contact with a side spring portion of a seat back spring, the gas generating device is positioned rearward of a moved-back imaginary line in the seat front-rear direction and outward of the moved-back imaginary line in the seat-width direction.
Owner:TOYOTA JIDOSHA KK
Information Recording/Reproducing Apparatus
InactiveUS20080310498A1Improve compatibilityIncrease in sizeTelevision system detailsPicture reproducers using cathode ray tubesComputer hardwareUsability
There are provided an information recording / reproducing apparatus and a video camera, both compliant with plural standards and excellent in usability, within an advantageously earlier stage by simplifying a circuit configuration and reducing the development steps and time period. A compression / extension module includes a common compression / extension module which performs a process of a compression method common in plural standards. For example, the common compression / extension module common between the AVCHD standard and the BD standard performs a process of the H.264 compression method for a video signal, and performs a process of the Dolby Digital compression method for an audio signal. A format controlling module includes a common format generating module which performs a formatting process common in plural standards. For example, the common format generating module common between the AVCHD standard and the BD standard generates a format including data structures and directories, in compliance with the BDMV subset.
Owner:HITACHI LTD
Tau imaging probe
An object of the present invention is to provide a probe for imaging a β-sheet structure protein which can be used for the diagnosis of conformational diseases, particularly disease (tauopathy) having a cardinal symptom such as intracerebral accumulation of tau protein, for example, Alzheimer's disease. Another object of the present invention is to provide a compound which is highly specific to tau and can image tau with satisfactory sensitivity, and also has high brain transition, low or non-recognized bone-seeking properties and low or non-recognized toxicity.According to the present invention, the above problems are solved by providing a compound of a formula I (wherein A, R1, R2, R3, R4, R5, R6, Ra and Rb are as defined in the present description) or a pharmaceutically acceptable salt or solvate thereof.
Owner:CLINO
Wafer for forming imaging element, method for manufacturing solid-state imaging element, and imaging element chip
ActiveUS9343508B2Solve the lack of functionHigh yieldElectronic circuit testingFinal product manufactureTectorial membraneEngineering
A wafer for forming an imaging element has a test pattern and a plurality of imaging element units. The wafer has an imaging region which includes a great number of photoelectric conversion pixels, an imaging element units and a test pattern. The test pattern includes a testing organic photoelectric conversion film and a testing counter electrode having the same configuration and formed at the same time as the organic photoelectric conversion film and a counter electrode, respectively of the photoelectric conversion pixels. A first testing terminal is electrically connected to the undersurface side of the testing organic photoelectric conversion film, and a second testing terminal is electrically connected to the testing counter electrode. A protective film is formed over the entire semiconductor wafer so as to cover the imaging region and the test pattern, and is then partially removed so that a part of each testing terminal is exposed.
Owner:FUJIFILM CORP
DNA conformation (loop structures) in normal and abnormal gene expression
ActiveUS20180080081A1Easy to detectEarly stageMicrobiological testing/measurementChromosome StructuresBiology
Owner:OXFORD UNIV INNOVATION LTD
Detecting circuit, modulation scheme identifying circuit, integrated circuit, tuning device, and common multi-scheme receiving device
InactiveUS20080075200A1Reduce circuit sizeReduce power consumptionAmplitude demodulation by homodyne/synchrodyne circuitsSimultaneous amplitude and angle demodulationFrequency conversionSoftware engineering
A plurality of detectors are included which have different detection frequencies. The detectors detect the signal level of an IF signal at the respective detection frequencies. The IF signal is produced by frequency conversion of an incoming signal in a mixing section. A comparator identifies the modulation scheme of the incoming signal from a comparison of the signal levels detected by the detectors. Accordingly, a detecting circuit is realized which is contained in a common multi-scheme receiver receiving a plurality of transmission signals with different modulation schemes and which identifies various modulation schemes for incoming signals.
Owner:SHARP KK
DNA conformation (loop structures) in normal and abnormal gene expression
ActiveUS9777327B2Easy to detectEarly stageMicrobiological testing/measurementChromosome StructuresBiology
Owner:OXFORD UNIV INNOVATION LTD
Biomarker and method for evaluating risk of proliferation, invasion, or metastasis of cancer
ActiveUS20120282597A1Accurate predictionEffective treatmentElectrolysis componentsParticle separator tubesNon cancerLymphatic Spread
The present invention relates to a biomarker associated with a cancer and a method using the biomarker to evaluate a risk of proliferation, invasion, or metastasis of a cancer. The method of the present invention comprises the following steps: (A) providing a tissue sample to evaluate for risk of proliferation, invasion, or metastasis of a cancer, wherein the tissue sample comprises a non-cancer region, and a suspected cancer region; (B) detecting expression levels of a biomarker and a predetermined standard in the non-cancer region and the suspected cancer region respectively, wherein the biomarker is T-cell lymphoma invasion and metastasis 2 (TIAM2); (C) comparing the expression levels of the biomarker and the predetermined standard in the non-cancer region to the expression levels of the biomarker and the predetermined standard in the suspected cancer region.
Owner:NAT CHENG KUNG UNIV
Device for prevention of shunt stenosis
ActiveUS9675748B2Easy constructionAvoid problemsBalloon catheterOther blood circulation devicesVeinHaemodialysis machine
A method and a kit for the prevention of venous stenosis associated with the use of hemodialysis AV shunts. The kit may use a bifurcated needle for providing access to the shunt or blood vessel. One of the arms is used for returning the blood to the subject after dialysis treatment, while the other arm is used for inserting a device for cleaning the vein, the device being either an autonomous crawling device, or a passive tethered device moved down the vein by the blood flow. The autonomous crawling device may be a series of sequentially inflatable chambers, the stenosis being cleared by pressure from the outer walls of the chambers when inflated and moved. The passive device may be an element having a flexible disc-like structure, whose flexible peripheral edge slides along the inner walls of the blood vessel, compressing or clearing the material attached thereto.
Owner:MICROBOT MEDICAL LTD
Epigenetic chromosome interactions
PendingUS20190071715A1Increases chanceSaving time and moneyNervous disorderAntipyreticEarly rheumatoid arthritisJuvenile rheumatoid arthritis
Owner:OXFORD BIODYNAMICS PLC
System, computer-readable medium, method, and use for combined epithelial early cancer diagnosis and staging
InactiveUS8374685B2Early stageEarly detectionRadiation pyrometryPolarisation spectroscopyPath lengthMedicine
A system (40) for diagnosis and staging of early stages of cancer in the tissue of a patient is provided. The system—is configured to combine information from a Polarized Light Scattering Spectroscopy measurement (70) having a first probe depth, and a Differential Path Length Spectroscopy measurement (60) having a second probe depth, wherein the second probe depth is set larger than' the first probe depth. By comparing the results of the Polarized Light Scattering Spectroscopy and Differential Path Length Spectroscopy measurements early stages of cancer, such as dysplasia may be detected. Also hyperplasia, carcinoma in situ, and carcinoma may be detected. A computer-readable medium, method and use are also provided.
Owner:KONINK PHILIPS ELECTRONICS NV
Biomarker and method for evaluating risk of proliferation, invasion, or metastasis of cancer
ActiveUS8679760B2Accurate predictionEffective treatmentSugar derivativesMicrobiological testing/measurementNon cancerTissue sample
The present invention relates to a biomarker associated with a cancer and a method using the biomarker to evaluate a risk of proliferation, invasion, or metastasis of a cancer. The method of the present invention comprises the following steps: (A) providing a tissue sample to evaluate for risk of proliferation, invasion, or metastasis of a cancer, wherein the tissue sample comprises a non-cancer region, and a suspected cancer region; (B) detecting expression levels of a biomarker and a predetermined standard in the non-cancer region and the suspected cancer region respectively, wherein the biomarker is T-cell lymphoma invasion and metastasis 2 (TIAM2); (C) comparing the expression levels of the biomarker and the predetermined standard in the non-cancer region to the expression levels of the biomarker and the predetermined standard in the suspected cancer region.
Owner:NAT CHENG KUNG UNIV
Decision feedback equalizer and related control method
ActiveUS11283653B2Suppress energyImprove stabilityTransmitter/receiver shaping networksControl engineeringControl theory
A decision feedback equalizer for generating an output signal according to an input signal includes: a feedforward equalizer, a feedback equalizer and a weight coefficient control unit. The feedforward equalizer includes a plurality of tapped delay lines and is controlled by a set of first weight coefficients. The feedback equalizer includes a plurality of tapped delay line and is controlled by a set of second weight coefficients. The weight coefficient control unit is employed to selectively adjust at least one of the set of first weight coefficients and determine a set of first boundary values for at least one of the set of second weight coefficients. When the at least one of the set of second weight coefficients does not exceed the set of first boundary values, the weight coefficient control unit increments the at least one of the set of first weight coefficients.
Owner:REALTEK SEMICON CORP
Screening method for compound inhibiting development or progression of familial amyotrophic lateral sclerosis and diagnostic method for familial amyotrophic lateral sclerosis
InactiveUS20090269794A1Early stageInhibit onset and progressionMicrobiological testing/measurementCulture cellAmyotrophic lateral sclerosis
A screening method comprising the following steps is provided.A step of culturing cells in the presence and in the absence of a test compound,a step of measuring HIF-1α expression in the respective cultured cells, anda step of determining the test compound to be a compound that inhibits onset or progression of familial amyotrophic lateral sclerosis if the HIF-1α expression in the cells cultured in the presence of the test compound is less than the HIF-1α expression in the cells cultured in the absence of the test compound.
Owner:HISAMITSU PHARM CO INC +1
Permeable and decomposable plug forming rapidly dehydrating fluid (RDF)
ActiveUS10988666B2Mitigate and prevent circulationPrevent and reduce lossFlushingDrilling compositionCelluloseTree trunk
A rapidly dehydrating fluid (RDF) composition that forms a permeable and decomposable plug and methods of lost circulation control and manufacture of the RDF composition. The RDF composition may include a carrier fluid such as water, a cellulosic microfiber viscosifier, date tree seed particles, and fibers formed from date tree waste such as date tree trunks. The RDF composition may mitigate or prevent lost circulation by forming a decomposable plug in a fracture of the lost circulation zone and may also enable the production of hydrocarbons from the zone without removal of the plug.
Owner:SAUDI ARABIAN OIL CO
Device for prevention of shunt stenosis
ActiveUS20170239401A1Easy constructionAvoid problemsBalloon catheterOther blood circulation devicesVeinHaemodialysis machine
A method and a kit for the prevention of venous stenosis associated with the use of hemodialysis AV shunts. The kit may use a bifurcated needle for providing access to the shunt or blood vessel. One of the arms is used for returning the blood to the subject after dialysis treatment, while the other arm is used for inserting a device for cleaning the vein, the device being either an autonomous crawling device, or a passive tethered device moved down the vein by the blood flow. The autonomous crawling device may be a series of sequentially inflatable chambers, the stenosis being cleared by pressure from the outer walls of the chambers when inflated and moved. The passive device may be an element having a flexible disc-like structure, whose flexible peripheral edge slides along the inner walls of the blood vessel, compressing or clearing the material attached thereto.
Owner:MICROBOT MEDICAL LTD
Permeable and Decomposable Plug Forming Rapidly Dehydrating Fluid (RDF)
ActiveUS20200317987A1Reduce probabilityMitigate and prevent circulationFlushingDrilling compositionCelluloseTree trunk
A rapidly dehydrating fluid (RDF) composition that forms a permeable and decomposable plug is provided. The RDF composition may include a carrier fluid such as water, a cellulosic microfiber viscosifier, date tree seed particles, and fibers formed from date tree waste such as date tree trunks. The RDF composition may mitigate or prevent lost circulation by forming a decomposable plug in a fracture of the lost circulation zone and may also enable the production of hydrocarbons from the zone without removal of the plug. Methods of lost circulation control and manufacture of the RDF composition are also provided
Owner:SAUDI ARABIAN OIL CO
Permeable and Decomposable Plug Forming Rapidly Dehydrating Fluid (RDF)
ActiveUS20200317988A1Reduce probabilityMitigate and prevent circulationFlushingDrilling compositionCelluloseTree trunk
A rapidly dehydrating fluid (RDF) composition that forms a permeable and decomposable plug is provided. The RDF composition may include a carrier fluid such as water, a cellulosic microfiber viscosifier, date tree seed particles, and fibers formed from date tree waste such as date tree trunks. The RDF composition may mitigate or prevent lost circulation by forming a decomposable plug in a fracture of the lost circulation zone and may also enable the production of hydrocarbons from the zone without removal of the plug. Methods of lost circulation control and manufacture of the RDF composition are also provided
Owner:SAUDI ARABIAN OIL CO
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com